Uric Acid Reduction Probiotics Premix - ZC-URA from China Suppliers | Clinical Strains from Trusted Factory
Deposite: CCTCC M 2020833
Shelf life: 24 months
Storage conditions: Stored at -18℃or lower
Health Benefits
Functional Strains
Lacticaseibacillus paracasei X11
Lacticaseibacillus paracasei Lpc-C66
Bifidobacterium animalis subsp. lactis KV9
Bifidobacterium animalis subsp. lactis F1-7
Main Functions
1 Clinical Verification
4 Patents for Invention
17 Research Publications
- Reduce purine intake
- Alleviate gout symptoms
- Improve hepatic and renal metabolism
Clinical Research Institution: Guangdong Second Provincial Hospital – a Tertiary Grade A Hospital
Clinical registration number: ChiCTR2500096029—A randomized, double-blind, placebo-controlled feeding study of compound Lactobacillus powder in patients with hyperuricemia (with or without gout).
√
Within 8 weeks, uric acid decreased by nearly 20%, with a maximum reduction of 207 μmol/L
√
Gout attacks reduced by 47%, and symptom duration shortened by 69%
√
Reduced use of emergency gout medications
No. 1 in China · Collaboration with Grade III Class A Hospital · Clinically Evidenced Functional Probiotic Strain
Tertiary Hospital · Clinical Evidence-Based Medicine
A Randomized, Double-blind, Placebo-controlled Feeding Trial of Purineed™ Premix Probiotics Powder in Patients with Hyperuricemia (With or Without Gout).
Research Institution: Guangdong Second Provincial General Hospital (a Grade III, Level A general hospital)
Total Sample Size: 50 patients with hyperuricemia (with or without gout) (mean serum uric acid level: 554 μmol/L)
Intervention Duration: 8 consecutive weeks of trial consumption
Primary Efficacy Indicators: Changes in serum uric acid levels, frequency of acute gout attacks, and use of emergency medication for acute gout attacks, etc.
Intervention Protocol: 2g, twice daily
Clinical Data 1: Changes observed over 8 weeks, with 72% of subjects showing a decrease in serum uric acid levels.
Trial Notes:
The 8-week trial demonstrated that Purineed™ exhibited a significant uric acid-lowering effect. 72% of the subjects experienced a reduction in uric acid levels, with the decrease generally around 20%. Serum uric acid levels decreased by up to 207 μmol/L, significantly lower than individual baseline values.
Clinical Data 2: Gout attack frequency was reduced by 47%, and the attack duration was shortened by 69%.
Trial Notes:
Compared to the control group, Purineed™ significantly reduced the frequency of acute gout attacks by 47% and shortened the attack duration by approximately 69% (representing a 3.3-fold relative improvement in efficacy). This indicates that Purineed™ can effectively decrease the frequency of gout flare-ups and mitigate the severity of acute attacks, aiding in recovery.
Clinical Data 3: Reduced Medication Use – 100% of Users Required No Emergency Gout Medication
Trial Notes:
After 8 weeks of trial consumption, the number of emergency medication uses in the test group was zero. 100% of the subjects in the test group did not require emergency medication due to acute gout attacks. This indicates that Purineed™ can effectively help individuals with hyperuricemia/gout avoid acute gout attacks, thereby reducing or even eliminating the need for emergency medication.
Clinical Report Summary
Purineed™ Premix Probiotics powder has been shown to lower serum uric acid levels, significantly reduce reliance on emergency gout medication, decrease the frequency of gout attacks, and shorten their duration. The effects demonstrated potential sustainability, and the product exhibited a favorable overall safety profile.
*The above is a data excerpt. For detailed clinical reports, please consult Zhongchuang Yike (Shanghai) Biotechnology Co., Ltd. at 400-166-7858.
Frequently Asked Questions
Q
Which probiotic strains are included in this functional formula?
The functional formulation contains four specific probiotic strains: Lacticaseibacillus paracasei X11, Lacticaseibacillus paracasei Lpc-C66, Bifidobacterium animalis subsp. lactis KV9, and Bifidobacterium animalis subsp. lactis F1-7.
Q
What are the primary health functions of Purineed™?
The primary functions of Purineed™ Premix Probiotics include reducing purine intake, alleviating gout symptoms, and improving hepatic and renal metabolism.
Q
How effective is Purineed™ in lowering serum uric acid levels?
Clinical trial results show that within 8 weeks, 72% of subjects experienced a reduction in serum uric acid levels, with an average reduction of nearly 20% and a maximum recorded decrease of 207 μmol/L.
Q
Does Purineed™ help reduce the frequency and duration of gout attacks?
Yes. Clinical data demonstrates that the frequency of acute gout attacks was reduced by 47%, and the duration of these attacks was shortened by approximately 69% (representing a 3.3-fold relative improvement in efficacy).
Q
Can this probiotic powder reduce the reliance on emergency gout medications?
Yes. Following the 8-week trial, 100% of the subjects in the test group did not require emergency medication for acute gout attacks, showing a complete reduction in the need for emergency intervention.